Thermo Fisher Scientific Inc (NYSE:TMO)
| 541.95 Delayed Data As of May 13 |  0.00 / 0.00%Today’s Change | 438.72 Today|||52-Week Range 672.34 | -18.78% Year-to-Date |
Latest TMO News | Press Releases
Today’s Trading
| Previous close | 541.95 |
| Today’s open | 533.91 |
| Day’s range | 533.14 - 551.77 |
| Volume | 59,557 |
| Average volume (3 months) | 1,604,653 |
| Market cap | $211.9B |
Data as of 4:00pm ET, 05/13/2022
Growth & Valuation
| Earnings growth (last year) | +21.79% |
| Earnings growth (this year) | -9.25% |
| Earnings growth (next 5 years) | +12.00% |
| Revenue growth (last year) | +21.71% |
| P/E ratio | 28.2 |
| Price/Sales | 6.76 |
| Price/Book | 5.24 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| DHRDanaher Corp | +2.60 | +1.06% |
| AAgilent Technologies... | +2.78 | +2.31% |
| MTDMettler-Toledo Inter... | +2.87 | +0.23% |
| WATWaters Corp | +10.93 | +3.41% |
Data as of 05/17/2022
Financials
| Next reporting date | July 27, 2022 |
| EPS forecast (this quarter) | $5.01 |
| Annual revenue (last year) | $39.2B |
| Annual profit (last year) | $7.7B |
| Net profit margin | 19.70% |
Profile
Sector Health Technology |
Industry Medical Specialties |
No executives to display |
Corporate headquarters Waltham, Massachusetts |
Forecasts
Chart unavailable
